Bongani Mayosi South African researcher
Mayosi, Bongani M., 1967-2018
VIAF ID: 307482065 ( Personal )
Permalink: http://viaf.org/viaf/307482065
Preferred Forms
4xx's: Alternate Name Forms (6)
Works
| Title | Sources |
|---|---|
| Measured haplotype analysis of the aldosterone synthase gene and heart size. |
|
| Medical inpatient mortality at Groote Schuur Hospital, Cape Town, South Africa, 2002-2009. |
|
| Medical therapy of pericardial diseases: part II: Noninfectious pericarditis, pericardial effusion and constrictive pericarditis |
|
| The mitochondrial DNA T16189C polymorphism and HIV-associated cardiomyopathy: a genotype-phenotype association study |
|
| Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. |
|
| Motion-guided segmentation for cine DENSE MRI |
|
| Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies |
|
| Mutations of FAM111B gene are not associated with Systemic Sclerosis |
|
| Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic Review |
|
| National expenditure on health research in South Africa: what is the benchmark? |
|
| The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study |
|
| Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building—Reply |
|
| Novel genetic variants linked to coronary artery disease by genome-wide association are not associated with carotid artery intima-media thickness or intermediate risk phenotypes. |
|
| Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications |
|
| Origins of computed tomography. |
|
| The Pacemaker and ICD Reuse Programme of the Pan-African Society of Cardiology. |
|
| "I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa |
|
| The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa. |
|
| Peripartum cardiomyopathy and familial dilated Cardiomyopathy: a tale of two cases |
|
| Pharmacotherapy: Colchicine for recurrent pericarditis--what's new in CORP-2? |
|
| Poikiloderma, tendon contracture and pulmonary fibrosis: a new autosomal dominant syndrome? |
|
| Politicians must heed health effects of climate change |
|
| Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis |
|
| Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease |
|
| Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study |
|
| Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis |
|
| Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy |
|
| The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature |
|
| Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies |
|
| Prevalence of group A streptococcal disease in North and Sub-Saharan Africa: a systematic review protocol |
|
| Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic |
|
| Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia |
|
| Primary prevention of rheumatic fever in children: Key factors to consider |
|
| Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: insight from the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF). |
|
| A programme to increase appropriate usage of benzathine penicillin for management of streptococcal pharyngitis and rheumatic heart disease in Zambia. |
|
| The promise of computer-assisted auscultation in screening for structural heart disease and clinical teaching. |
|
| Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey. |
|
| Quantification of echodensities in tuberculous pericardial effusion using fractal geometry: a proof of concept study |
|
| A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. |
|
| Rationale and design of the African group A streptococcal infection registry: the AFROStrep study |
|
| Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention |
|
| Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis. |
|
| Readiness of the primary care system for non-communicable diseases in sub-Saharan Africa |
|
| Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa |
|
| Reference intervals for the echocardiographic measurements of the right heart in children and adolescents: a systematic review |
|
| Renal dysfunction in African patients with acute heart failure |
|
| Reply |
|
| Research capacity. Enabling the genomic revolution in Africa |
|
| Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association |
|
| Rheumatic fever: neglected again. |
|
| Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action. |
|
| Rheumatic heart disease: social and economic dimensions. |
|
| Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel |
|
| Roadmap to achieve 25% hypertension control in Africa by 2025. |
|
| Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction |
|
| Securing the public good of health research and development for developing countries |
|
| STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression |
|
| Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce |
|
| Symptoms and Signs of Heart Failure at Admission and Discharge and Outcomes in the Sub-Saharan Acute Heart Failure (THESUS-HF) Registry |
|
| A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa |
|
| A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion. |
|
| Systems medicine and integrated care to combat chronic noncommunicable diseases |
|
| Time to tackle rheumatic heart disease: Data needed to drive global policy dialogues |
|
| Towards host-directed therapies for tuberculosis |
|
| Tracking myocardial motion from cine DENSE images using spatiotemporal phase unwrapping and temporal fitting. |
|
| Transmissible cancer in Africa – Authors' reply |
|
| Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. |
|
| Tuberculous pericarditis with and without HIV. |
|
| Use of broad consent and related procedures in genomics research: Perspectives from research participants in the Genetics of Rheumatic Heart Disease (RHDGen) study in a University Teaching Hospital in Zambia |
|
| Using reconditioned pacemakers to treat bradycardia in Africa |
|
| Utilization of implantable defibrillators in Africa. |
|
| Wytyczne ESC dotyczące rozpoznawania i leczenia chorób osierdzia w 2015 roku |
|
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 |
|
| প্রত্যুত্তর |
|
